References
- Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902):359–62
- Fried MW, Hoofnagle JH. Therapy of hepatitis C. Semin Liver Dis 1995; 15(1):82–91
- Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23(3):437–55
- Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15(1):5–14
- Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extra-hepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122(3):169–73
- Tedeschi V, Seeff LB. Diagnostic tests for hepatitis C: where are we now? (Editorial) Ann Intern Med 1995; 123(5): 383–5
- Shiomi S, Kuroki T, Minamitani S, et al. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992; 7(3):274–6
- Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology 1995; 26(4):297–309
- Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21(2):570–83
- Multicenter Study Group. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332(22):1457–62 [Erratum, N Engl J Med 1996; 334(17): 1143]
- Castillo I, Bartolome J, Navas S, et al. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 1994; 19(6):1342–6
- Watanabe U, Hashimoto E, Hisamitsu T, et al. The risk factor for development of thyroid disease during interferon α therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89(3):399–403
- Hoofnagle JH. Therapy of acute and chronic viral hepatitis. Adv Intern Med 1994; 39:241–75
- Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14(6):969–74
- Jouet P, Roudot-Thoraval F, Dhumeaux D, et al, for Le Groupe Francais pour 1'Etude du Traitement des Hepatites Chroniques (NANB/C). Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 1994; 106(3):686–90